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Abstract While squamous cell carcinoma (SCC) is the
most common tracheal malignancy, few reports describe the
pathologic considerations that may guide intraoperative
decisions and prognostic assessment. We reviewed 59
tracheal SCC treated between 1985 and 2008 by segmental
resection of the trachea, including resection of the carina in
24% and inferior larynx in 14%. We classified these tumors
by grading histologic differentiation and microscopic
features used in SCC of other sites. Of 59 tumors, 24%
(14 of 59) were well differentiated, 49% (29 of 59) were
moderately differentiated, and 27% (16 of 59) were poorly
differentiated. Unfavorable prognostic factors were tumor
extension into the thyroid gland (all of five so-afflicted
patients died of tumor progression within 3 years) and
lymphatic invasion (mean survival 4.6 versus 7.6 years).
Keratinization, dyskeratosis, acantholysis, necrosis, and
tumor thickness did not predict prognosis. As surgical
resection is the only curative treatment; the surgeon should
establish clean lines of resection using, as appropriate,
intraoperative frozen section. The pathologist can provide
additional important prognostic information, including
tumor differentiation and extent, invasion of surgical
margins, and extension into the thyroid.
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Introduction
Although squamous cell carcinoma (SCC) accounts for
more than half of all tracheal tumors [1], the pathologic
features in resection specimens and the impact of these
features on survival have only been described in small
series [2]. At least two staging systems have been proposed
for tracheal malignancies; one, a cross-sectional analysis of a
national cancer database by Bhattacharyya, is based on
retrospective tumor–node–metastases (TNM) documentation
correlated with survival statistics in 41 squamous cell
carcinomas, 19 adenoid cystic carcinomas, and 32 tumors
of other histology [3], although a TNM staging system
validated by clinical and pathologic evidence for this disease
does not exist. The other, by Macchiarini, is a nonvalidated
TNM classification [4]. Both classifications are intended to
be applied to all histologic types of tracheal cancer.
We describe specific pathologic features of primary
tracheal SCC in a large series of surgical specimens from a
single institution to identify prognostic predictors of survival.
Materials and methods
A retrospective analysis was conducted of consecutive
patients who underwent resection for primary SCC of the
trachea from 1985 to 2008 at Massachusetts General
Hospital (MGH) and for whom pathology slides or blocks
were available. All except four patients were included in a
previous report describing the surgical results [5]. We
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DOI 10.1007/s00428-009-0843-6Fig. 1 a Cross section of trachea with exophitic tumor attached to
anterior wall; b lymphatic invasion in peritracheal adventitia; c
squamous cell carcinoma in situ, with full thickness replacement of
epithelium by cells with hyperchromatic nuclei and lack of surface
maturation; d cancerization of mucus ducts and glands by malignant
squamous cells but no invasion beyond basement membrane; e
squamous cell carcinoma invading from surface epithelium into
lamina propria and eliciting inflammation and fibrosis but not as far
as tracheal cartilage (bottom)
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completed tumor excision after a first resection elsewhere.
One patient underwent three resections, but only the first, for
tumor resection, was included in this study. Pathology
reports, operative reports, and hospital charts were reviewed
to exclude laryngeal cancer and tumors of the lung that
extended to the carina. The MGH institutional review board
approved the most recent protocol (no. 2008-P-000113) in
January 2008.
Types of resection
The surgical technique has been detailed previously [6].
For standard tracheal resection, a sleeve of trachea was
removed with end-to-end reconstruction, resulting in two
airway margins and a radial soft tissue margin. When
tracheal resection was combined with laryngectomy,
cervical or mediastinal end-tracheostomy was required.
For laryngotracheal resection, the tumor was removed
with a portion of infraglottic larynx while preserving at
least one recurrent laryngeal nerve not involved with
tumor. Reconstruction was achieved by shaping the
remaining trachea to conform to the laryngeal defect.
Carinal resection was performed with or without con-
comitant lung resection resulting in either two or three
airway margins, respectively. Systematic lymph node
dissection is assumed to interfere with the tracheal blood
supply and was therefore not performed. Regional lymph
nodes were often not included in the specimen if not
grossly enlarged. Absence of tumor at the airway margins
was confirmed by frozen section, unless the limits of
resection had been reached, and no additional trachea
could be removed.
Pathologic review and tumor data
In all reviewed cases, photographs of the resected specimen
(Fig. 1a) and slides stained with hematoxylin and eosin
were retrieved. Slides were recut from stored blocks if
necessary. Pathologic review of two or more slides per case
was done in each case by a senior pulmonary pathologist
(E.J.M.), on average four to six slides of the tumor itself
and additional slides of resection margins and lymph nodes.
The following histologic features were scored: degree of
differentiation based on degree and extent of nuclear
pleomorphism, using the criteria for well, moderately, or
poorly differentiated subtypes in the Armed Forces Institute
of Pathology Atlas of Tumor Pathology [7]; tumor
thickness, defined as the distance from the luminal tumor
surface to the farthest extent of invasion; keratinization;
necrosis; dyskeratosis; acantholysis; and lymphatic invasion
(Fig. 1b). Since no TNM-based staging system currently
exists for tracheal carcinoma, depth of tumor invasion into
the tracheal wall was scored according to a system devised
for the study as shown in Fig. 2, with both squamous cell
carcinoma in situ (Fig. 1c) and invasion of carcinoma into
tracheal mucus glands and ducts (so-called cancerization,
Fig. 1d) considered level 0 and superficially invasive
(Fig. 1e) as grade 1.
Further, operative and pathology reports were reviewed
f o rl e n g t ho fr e s e c t i o ni nt h el o n ga x i so ft h ea i r w a ya n d
the presence of tumor metastasis in lymph nodes. Since
lymph node excision in tracheal resection occurs merely
sporadically, we combined cases with positive lymph node
biopsy and cases with lymphatic invasion on histologic
examination in order to provide a meaningful, albeit
restricted, analysis.
Adjuvant radiotherapy
Postoperative radiotherapy was usually recommended at a
dose of 54 Gy 6 to 8 weeks after resection and often
administered outside Massachusetts General Hospital.
Follow-up
Patients and the MGH cancer registry were contacted for
follow-up information. The Social Security Death Index
was searched. Patients were determined to have died if
name, date of birth, and social security number matched.
The survival period began on the day of operation and was
concluded by death.
Statistical analysis
Overall survival after airway resection was calculated using
the Kaplan–Meier procedure with the log rank test
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Fig. 2 Depth of invasion in tracheal squamous cell carcinoma ranked
by levels. Tumor invaded between cartilage plates and not through the
cartilage. Level definitions: 0 carcinoma in situ, 1 infiltrating lamina
propria, 2a abutting or extending between cartilage, 2b invading
beyond cartilage, 3a invading peritracheal fibroadipose tissue, 3b
abutting soft tissue resection margin, 4 invading into thyroid gland
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(SPSS Inc, Chicago, IL), in contrast to the earlier report that
used an actuarial method [5]. Categorical variables were
compared with the chi-square test, and covariate analysis
was done with Pearson’s bivariate analysis.
Results
Since 1985, 75 patients have undergone surgical resection
for tracheal SCC at Massachusetts General Hospital. There
were no operative deaths. Slides or blocks were retrieved
in 64 cases, of which five were excluded: there was no
viable tumor after radiotherapy in three patients, a
cutaneous SCC occurred at a tracheostomy site in one,
and two separate SCC were present in one other patient, of
which only one was resected. Thus, the study included 59
cases.
Overall characteristics
There were 44 men (75%) and 15 women (25%) with a
mean age of 61.9 years (range 29 to 79 years). Prior
locoregional or preoperative radiotherapy was administered
in 24% (14 of 59). Resection involved trachea only in 63%
(37 of 59), trachea and carina in 24% (14 of 59), and
trachea and larynx in 14% (eight of 59) of cases. Mean
length of resected airway was 3.2 cm (range 1 to 6 cm).
Pathologic subgroup Number Percent Mean survival (years) P value Survival (%)
5-year 10-year
Tumor differentiation
Well differentiated 14 23.7 8.8 0.164 73 55
Moderately differentiated 29 49.2 6.3 44 25
Poorly differentiated 16 27.1 4.5 29 10
Keratinization
Yes 39 66.1 6.5 0.719 50 28
No 20 33.9 6.6 39 26
Necrosis
Extensive 12 20.3 7.2 0.726 46 27
Focal 28 47.5 6.1 45 26
No 19 32.2 6.2 47 30
Dyskeratosis
Yes 35 59.3 6.7 0.942 51 34
No 24 40.7 6.3 39 20
Acantholysis
Yes 16 27.1 5.6 0.307 47 31
No 43 72.9 6.9 46 26
Lymphatic invasion
Yes 22 37.3 4.6 0.049 24 24
No 37 62.7 7.6 60 31
Depth of invasion
Level 0 2 3.4 n.a. 0.001 100 100
Level 1 5 8.5 7.6 75 25
Level 2a 14 23.7 6.0 50 25
Level 2b 11 18.6 7.1 50 38
Level 3a 16 27.1 7.7 53 31
Level 3b 6 10.2 2.1
Level 4 5 8.5 1.4 0
Tumor thickness
0.1–1.0 cm 29 49.2 6.8 0.650 48 32
1.1–2.0 cm 21 35.6 6.8 56 26
>2.0 cm 9 15.3 4.1 13 13
Overall 59 100.0 6.5 46 27
Table 1 Survival according to
pathologic subgroups
426 Virchows Arch (2009) 455:423–429Pathologic characteristics are listed in Table 1. Postopera-
tive radiation was documented in 42.4% of patients (25 of
59). We know of no patient who received postoperative
chemotherapy.
Follow-up and overall survival
Mean follow-up in 59 cases was 5.5 years (range 1 month
to 18.3 years). Survival information was complete in
90% of patients (53 of 59). Mean survival was 6.5 years,
and the 5- and 10-year survivals were 46% and 27%,
respectively. Table 1 shows the survival calculated for
each subgroup.
Differentiation
A majority of tumors had moderate differentiation, while
close to half were equally distributed between well and
poorly differentiated. Survival was longer in well-
differentiated tumors, though this difference was not
significant (Fig. 3a). Survival in well-differentiated carci-
nomas was 8.8 years versus 5.8 years in the group of
moderately and poorly differentiated carcinomas combined
(P=0.117).
Keratinization, necrosis, dyskeratosis, and acantholysis
Two thirds of tumors (39 of 59) showed keratinization.
Focal or extensive necrosis was present in 48% (28 of
59) and 20% (12 of 59), respectively. Necrosis was
present significantly more frequently in moderately and
poorly differentiated tumors (82%, 37 of 45) compared
to well-differentiated tumors (21%, three of 14;
P<0.001). Dyskeratosis was seen in 59% and acantholysis
in 27%.
Survival was not significantly correlated with the presence
or absence of keratinization, necrosis, dyskeratosis, or
acantholysis.
Lymphatic invasion
In 22 cases (37%), there was tumor in peritracheal
lymphatics on histologic examination (seven cases), a
tumor-positive lymph node biopsy was present (nine), or
both (six). In the other 36 cases (61%), neither lymphatic
invasion nor lymph node metastasis was demonstrated.
Lymphatic invasion was correlated with the degree of
differentiation: histologic lymphatic invasion or tumor-
positive lymph node biopsies were present in one of 14
well-differentiated (7%), 13 of 29 moderately differentiated
(49%), and nine of 16 poorly differentiated (56%) tumors
(P=0.015). Survival in patients without lymphatic invasion
was higher than when lymphatic invasion was present (P=
Differentiation Number at risk
Well
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Lymphatic invasion Number at risk
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No
Depth of invasion Number at risk
Level 0
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9
Fig. 3 a–c Overall survival according to: a tumor differentiation, b
lymphatic invasion, c depth of tumor invasion
Virchows Arch (2009) 455:423–429 4270.049, Fig. 3b). There was no difference in survival
between patients who had lymphatic invasion only versus
patients with positive lymph nodes only, versus both
(P=0.382).
Depth of invasion
Carcinomas in situ (level 0) were uncommon, while tumor
invaded peritracheal fibroadipose tissue (level 3a) in 16
cases (27%), extended to the soft tissue resection margin
(level 3b) in six cases (10%), and invaded the thyroid
gland (level 4) in five cases (8%; Table 2). While both
patients with carcinoma in situ were alive without disease
9.6 and 15 years after resection, there was no difference in
survival between levels 1, 2 (a and b), and 3a (Table 1 and
Fig. 3c). Incomplete resection and involvement of the
thyroid gland were both negative prognostic markers:
mean survival was 2.1 years in patients with tumor at the
soft tissue resection margin (level 3b) and 1.4 years when
tumor invaded the thyroid gland (level 4), both signifi-
cantly lower than in other levels of invasion (P=0.025and
P<0.001, respectively). Lesser levels of invasion were
associated with a higher incidence of well-differentiated
histology (P=0.018) and a lower incidence of lymphatic
invasion (P=0.002).
Tumor thickness
Mean tumor thickness was 1.3 cm (median 1.1 cm, range
0.1–5.5 cm). Tumors were 2 cm or smaller in 85%. Within
this range, tumor thickness had no significant impact on
survival (P=0.650). Tumors of greater thickness were
associated with resections of greater (>3 cm) length (P=
0.008), although there were two resections of 2.0 and
2.5 cm in length of trachea with a tumor of 3 and 5 cm in
thickness, respectively (Fig. 4, correlation coefficient
0.364). Tumors >2 cm in thickness had no different survival
than tumors of 2 cm or less (P=0.353). Tumors >2 cm in
thickness more frequently invaded peritracheal fibroadipose
tissue (six of nine, 67%) than smaller tumors (ten of 50,
20%; P=0.004) but were not associated with levels 3b or 4
(Table 2).
Discussion
In this pathologic review of primary tracheal squamous cell
carcinoma, the largest series to date, we show that
completeness of resection, involvement of the thyroid
gland, and lymphatic invasion are histopathologic features
with important prognostic value. Increasing depth of
invasion into the tracheal wall is associated with a loss of
histologic differentiation and lymphatic invasion. Although
survival in well-differentiated carcinomas is higher, this
difference is not significant and may be attributed to the
higher incidence of lymphatic invasion in moderately and
poorly differentiated carcinomas. Further, we observed that
Fig. 4 Correlation between thickness and length of resected tracheal
tumor. Each data point represents one tumor specimen
Table 2 Pathologic characteristics according to depth of invasion
Depth of invasion Number Percent Well differentiated Lymphatic invasion Tumor thickness >2cm
N % N % N %
Level 0 2 3.4 2 100.0 0 0.0 0 0.0
Level 1 5 8.5 2 40.0 0 0.0 0 0.0
Level 2a 14 23.7 5 35.7 1 7.1 0 0.0
Level 2b 11 18.6 4 36.4 5 45.5 2 18.2
Level 3a 16 27.1 1 6.3 7 43.8 6 37.5
Level 3b 6 10.2 0 0.0 4 66.7 1 16.7
Level 4 5 8.5 0 0.0 5 100.0 0 0.0
Overall 59 100.0 14 23.7 22 37.3 9 15.3
428 Virchows Arch (2009) 455:423–429resected tracheal SCCs are mostly small tumors (median
thickness 1.1 cm) and that tumor thickness within this range
did not significantly affect prognosis. A possible explana-
tion for this finding is that thickness may result from the
exophitic portion of the tumor and thus is not conditioned
on deeper invasion into the tracheal wall. A higher
proportion of larger tumors, however, exhibit lymphatic
invasion, a significant predictor of survival.
Surgical resection may lead to excellent survival even
when the tumor violates the boundaries of the trachea and
invades peritracheal fibroadipose tissue. To provide the best
chances of survival, it is however important for the surgeon
to achieve negative soft tissue resection margins. When
faced with a tracheal SCC growing into the thyroid gland,
our findings indicate that surgical resection should be
applied to carefully selected patients, and palliative therapy
may be considered when complete resection is otherwise
compromised. Further, the pathologist reviewing SCC of
the trachea should be aware of the importance of lymphatic
invasion and specifically investigate the tumor for the
presence of this feature.
There are some limitations to our study. We retrospec-
tively analyzed large pathologic specimens of tracheal
SCC, and only resected cases were included. Tumors
growing into vital organs such as the heart or the great
vessels and tumors involving long segments of airway
judged unresectable were treated at the Massachusetts
General Hospital but are not included in our study. We
might have underestimated or misjudged the histologic
characteristics, as only a limited number of representative
slides for each case were available during histologic review;
further, there were only five cases with invasion of the
thyroid gland.
Tracheal SCC is a rare tumor, and few centers acquire
proficiency in its surgical treatment. The dissemination of
whatever prognostic information is available assumes
therefore a greater importance. We confirm that lymphatic
invasion predicts prognosis, while depth of invasion could
not be correlated with survival, except for a marked decline
when tumor was present at the resection margin or invaded
the thyroid gland. We therefore conclude that even in cases
where tumor invades peritracheal fibroadipose tissue,
excellent survival can be achieved provided the patient
undergoes surgical resection and the resection is complete.
Positive resection margins in turn predict treatment failure.
Our previous report showed that outcome in patients with
unresected tumors is worse than in patients that underwent
resection [5], a finding supported here by the poor
prognosis in patients with incomplete resection. Thus,
tumor resectability, usually dictated by tumor length in the
long axis of the airway and invasion of vital organs, may
possibly be the single most important prognostic factor in
this very distinct type of cancer.
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